According to BioNTech's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.12. At the end of 2024 the company had a P/S ratio of 9.20.
Year | P/S ratio | Change |
---|---|---|
2024 | 9.20 | 51.16% |
2023 | 6.09 | 207.97% |
2022 | 1.98 | -30.3% |
2021 | 2.84 | -91.6% |
2020 | 33.7 | -46.65% |
2019 | 63.3 |